Tag: Blood Disorders
Five-Year Relative Survival 59.6 Percent in Lower-Risk Myelodysplastic Syndromes
Five-year overall survival 47.3 percent in patients with lower-risk myelodysplastic syndromes
FDA Approves First Cell-Based Gene Therapy for Beta-Thalassemia
The single-dose treatment is approved for transfusion-dependent adults and children
Low Serum Urate Level Tied to Low Lean Mass, Underweight
Association of low serum urate with increased mortality not statistically significant after adjusting for body composition
Guideline Updated for Managing Hyperbilirubinemia in Newborns
All families should receive written and verbal education about neonatal jaundice before discharge
COVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose
Increased Blood Viscosity Linked to Mortality in COVID-19
Hospitalized COVID-19 patients with increased estimated blood viscosity may have greater risk for in-hospital mortality
Donor Sex, Parity Do Not Up Mortality for Red Blood Cell Recipients
After adjustment for donor hemoglobin levels, no increased risk seen for requiring additional transfusion after transfusion from female donor
AAD: Skin Videomicroscopy Biomarker May Help Predict Cancer Relapse
Assessment of leukocytes adherent to and rolling along vessel wall may help predict outcomes after HCT for hematologic cancer
Hyponatremia Hospitalizations Up With Rising Ambient Temps
Future 1- or 2-degree Celsius increase in mean temperature expected to increase incidence of hyponatremia by 6.3 and 13.9 percent, respectively
Gene Therapy Potentially Curative for β-Thalassemia
Transfusion independence, near-normal Hb levels seen for most children and adults receiving beti-cel for non-β0/β0 genotype β-thalassemia
